Related references
Note: Only part of the references are listed.Supramolecular peptide vaccines: tuning adaptive immunity
Yi Wen et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Hydrogels and Scaffolds for Immunomodulation
Ankur Singh et al.
ADVANCED MATERIALS (2014)
Injectable, self-gelling, biodegradable, and immunomodulatory DNA hydrogel for antigen delivery
Makiya Nishikawa et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Efficient delivery of immunostimulatory DNA to mouse and human immune cells through the construction of polypod-like structured DNA
Shota Uno et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
Charles Maisonneuve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Genuine Immunomodulation With dSLIM
Kerstin Kapp et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination
Mei-Chin Chen et al.
BIOMATERIALS (2013)
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
Daisuke Nobuoka et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Immune system targeting by biodegradable nanoparticles for cancer vaccines
Joana M. Silva et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
Alexandre de Titta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Injectable biodegradable hydrogels: progress and challenges
Ki Hyun Bae et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Design and Development of Nanosized DNA Assemblies in Polypod-like Structures as Efficient Vehicles for Immunostimulatory CpG Motifs to Immune Cells
Kohta Mohri et al.
ACS NANO (2012)
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Youn H. Kim et al.
BLOOD (2012)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies
Julia Karbach et al.
CANCER RESEARCH (2012)
Increased immunostimulatory activity of polypod-like structured DNA by ligation of the terminal loop structures
Kohta Mohri et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
Yuko Shirota et al.
JOURNAL OF IMMUNOLOGY (2012)
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Christine Zoglmeier et al.
CLINICAL CANCER RESEARCH (2011)
Progress in understanding adjuvant immunotoxicity mechanisms
Alexander Batista-Duharte et al.
TOXICOLOGY LETTERS (2011)
Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity
H. Mitsui et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The path to a successful vaccine adjuvant - 'The long and winding road'
Derek T. O'Hagan et al.
DRUG DISCOVERY TODAY (2009)
New horizons in adjuvants for vaccine development
Steven G. Reed et al.
TRENDS IN IMMUNOLOGY (2009)
Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation
Makiya Nishikawa et al.
IMMUNOLOGY (2008)
More than one reason to rethink the use of peptides in vaccine design
Anthony W. Purcell et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Hydrogels in controlled release formulations: Network design and mathematical modeling
Chien-Chi Lin et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses
Jessica B. Flechtner et al.
JOURNAL OF IMMUNOLOGY (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)
Induction of cytotoxic T lymphocytes following immunization with cationized soluble antigen
T Ikenaga et al.
VACCINE (2004)
Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity
AS Lonsdorf et al.
JOURNAL OF IMMUNOLOGY (2003)
Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity
H Wagner
CURRENT OPINION IN MICROBIOLOGY (2002)
Share Paper
